• Mashup Score: 2

    Older patients who present with a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) are at particular risk of recurrent ischaemic events, but also of bleeding complications.1 Choosing the optimal dual antiplatelet strategy for the ageing patient with ACS can thus present a dilemma in daily practice. Should dual antiplatelet therapy in an older patient include the less potent P2Y12…

    Tweet Tweets with this article
    • #Antiplatelet strategies in aging patients with acute coronary syndromes - The Lancet #ACS https://t.co/JGRPUdllE1

  • Mashup Score: 0

    New research shows no significant difference in the proportion of patients with gastrointestinal bleeding following anticoagulant or antiplatelet monotherapy.

    Tweet Tweets with this article
    • “We found [gastrointestinal bleeding] to occur in a higher proportion of patients prescribed combinations of anticoagulant and #antiplatelet agents compared with #monotherapy,” the authors of a new study wrote. https://t.co/mSxQ0CwzeD